ethylene glycol has been researched along with organophosphonates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borysko, KZ; Breitenbach, JM; Drach, JC; Eriksson, U; Hilfinger, JM; Kashemirov, BA; Kijek, P; Kim, JS; McKenna, CE; Mitchell, S | 1 |
| Gerlach, M; Hackenberger, CPR; Helma, J; Kasper, MA; Krause, E; Leonhardt, H; Ochtrop, P; Penkert, M; Schumacher, D; Stengl, A; Stoschek, T | 1 |
2 other study(ies) available for ethylene glycol and organophosphonates
| Article | Year |
|---|---|
Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir.
Topics: Amino Acids; Animals; Antiviral Agents; Biological Availability; Biotransformation; Cell Survival; Cidofovir; Cytosine; Ethylene Glycol; Half-Life; Humans; Hydrolysis; KB Cells; Magnetic Resonance Spectroscopy; Organophosphonates; Peptide Transporter 1; Phenylalanine; Prodrugs; Rats; Symporters; Valine; Viral Plaque Assay | 2007 |
Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody-Drug Conjugates.
Topics: Antineoplastic Agents, Immunological; Cysteine; Ethylene Glycol; Humans; Immunoconjugates; Organophosphonates; Receptor, ErbB-2; Trastuzumab; Tumor Cells, Cultured | 2019 |